Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Myriam Benlaifaoui"'
Autor:
Marion Tonneau, Alexis Nolin-Lapalme, Suzanne Kazandjian, Edouard Auclin, Justin Panasci, Myriam Benlaifaoui, Mayra Ponce, Afnan Al-Saleh, Wiam Belkaid, Sabrine Naimi, Catalin Mihalcioiu, Ian Watson, Mickael Bouin, Wilson Miller, Marie Hudson, Matthew K. Wong, Rossanna C. Pezo, Simon Turcotte, Karl Bélanger, Rahima Jamal, Paul Oster, Dominique Velin, Corentin Richard, Meriem Messaoudene, Arielle Elkrief, Bertrand Routy
Publikováno v:
OncoImmunology, Vol 11, Iss 1 (2022)
The microbiome is now regarded as one of the hallmarks of cancer and several strategies to modify the gut microbiota to improve immune checkpoint inhibitor (ICI) activity are being evaluated in clinical trials. Preliminary data regarding the upper ga
Externí odkaz:
https://doaj.org/article/adb7b6925dfe48898a2dcd6d9e30f8ad
Autor:
Corentin Richard, Bertrand Routy, Myriam Benlaifaoui, Omar El Ouarzadi, Khoudia Diop, Antoine Desilets, Julie Malo, Wiam Belkaid, Andréanne Leblanc, Julien Lamontagne, Meriem Messaoudene, Arielle Elkrief
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/e6283b609efd44a689f967c76ab118bc
Autor:
Bertrand Routy, Bastien Castagner, André Marette, Arielle Elkrief, Guido Kroemer, Sylvere Durand, Emmanuelle Le Chatelier, Oscar Gitton-Quent, Florian Plaza Oñate, Geneviève Pilon, Emilia Liana Falcone, Yves V. Brun, David T. Kysela, Sandy Chevrier, Romain Boidot, François Ghiringhelli, Didier Raoult, Paul Oster, Dominique Velin, Lharbi Dridi, Yves Fradet, Stephane Isnard, Wiam Belkaid, Julie Malo, Florent Cauchois, Alexis Nolin-Lapalme, Myriam Benlaifaoui, Khoudia Diop, Mayra Ponce, Corentin Richard, Reilly Pidgeon, Meriem Messaoudene
Supplementary Figure from A Natural Polyphenol Exerts Antitumor Activity and Circumvents Anti–PD-1 Resistance through Effects on the Gut Microbiota
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d53878c67784949fac07f86d3d9c437
https://doi.org/10.1158/2159-8290.22541432.v1
https://doi.org/10.1158/2159-8290.22541432.v1
Autor:
Bertrand Routy, Bastien Castagner, André Marette, Arielle Elkrief, Guido Kroemer, Sylvere Durand, Emmanuelle Le Chatelier, Oscar Gitton-Quent, Florian Plaza Oñate, Geneviève Pilon, Emilia Liana Falcone, Yves V. Brun, David T. Kysela, Sandy Chevrier, Romain Boidot, François Ghiringhelli, Didier Raoult, Paul Oster, Dominique Velin, Lharbi Dridi, Yves Fradet, Stephane Isnard, Wiam Belkaid, Julie Malo, Florent Cauchois, Alexis Nolin-Lapalme, Myriam Benlaifaoui, Khoudia Diop, Mayra Ponce, Corentin Richard, Reilly Pidgeon, Meriem Messaoudene
Several approaches to manipulate the gut microbiome for improving the activity of cancer immune-checkpoint inhibitors (ICI) are currently under evaluation. Here, we show that oral supplementation with the polyphenol-rich berry camu-camu (CC; Myrciari
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::774cbed002cf5fe66d2f547187bce8cc
https://doi.org/10.1158/2159-8290.c.6549638
https://doi.org/10.1158/2159-8290.c.6549638
Autor:
Meriem Messaoudene, Reilly Pidgeon, Corentin Richard, Mayra Ponce, Khoudia Diop, Myriam Benlaifaoui, Alexis Nolin-Lapalme, Florent Cauchois, Julie Malo, Wiam Belkaid, Stephane Isnard, Yves Fradet, Lharbi Dridi, Dominique Velin, Paul Oster, Didier Raoult, François Ghiringhelli, Romain Boidot, Sandy Chevrier, David T. Kysela, Yves V. Brun, Emilia Liana Falcone, Geneviève Pilon, Florian Plaza Oñate, Oscar Gitton-Quent, Emmanuelle Le Chatelier, Sylvere Durand, Guido Kroemer, Arielle Elkrief, André Marette, Bastien Castagner, Bertrand Routy
Publikováno v:
Cancer Discovery
Cancer Discovery, 2022, 12 (4), pp.1070-1087. ⟨10.1158/2159-8290.CD-21-0808⟩
Cancer Discovery, 2022, 12 (4), pp.1070-1087. ⟨10.1158/2159-8290.CD-21-0808⟩
Several approaches to manipulate the gut microbiome for improving the activity of cancer immune-checkpoint inhibitors (ICI) are currently under evaluation. Here, we show that oral supplementation with the polyphenol-rich berry camu-camu (CC; Myrciari
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18a105952b8704bcf86e6485365a5ab9
https://doi.org/10.1158/2159-8290.CD-21-0808
https://doi.org/10.1158/2159-8290.CD-21-0808
Autor:
Marion Tonneau, Corentin Richard, Alexis Nolin-Lapalme, Edouard Auclin, Myriam Benlaifaoui, Mayra Ponce, Afnan Al-Saleh, Normand Blais, Marie Florescu, Mustapha Tehfe, Julie Malo, Meriem Messaoudene, Yusuke Okuma, Taiki Hakozaki, Bertrand Routy
Publikováno v:
Journal of Clinical Oncology. 40:9036-9036
9036 Background: Despite immune-checkpoint inhibitors (ICI) achieving high response rates in patients (pts) with advanced non-small cell lung cancer (NSCLC), immune-related adverse events (irAE) remain an important therapeutic hurdle. The gut microbi
Autor:
Edouard Auclin, Alexis Nolin-Lapalme, Corentin Richard, Julie Malo, Marion Tonneau, Myriam Benlaifaoui, Mayra Ponce, Meriem Messaoudene, Yusuke Okuma, Taiki Hakozaki, Bertrand Routy
Publikováno v:
Journal of Clinical Oncology. 40:9050-9050
9050 Background: Host-related inflammatory biomarkers and gut microbiome are two major prognostic factors for non-small cell lung cancer (NSCLC) patients (pts) treated with immune checkpoint inhibitors (ICI). In this study, we aimed to assess an asso
Autor:
Taiki Hakozaki, Safae Terrisse, Yusuke Okuma, Iris Mimpen, Laurence Zitvogel, Bertrand Routy, Lisa Derosa, Arielle Elkrief, Corentin Richard, Myriam Benlaifaoui, Yukio Hosomi
Publikováno v:
Cancer immunology research. 8(10)
The gut microbiome (GM) plays an important role in shaping systemic immune responses and influences immune checkpoint inhibitor (ICI) efficacy. Antibiotics worsen clinical outcomes in patients receiving ICI. However, whether GM profiling and baseline
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Bertrand Routy, Corentin Richard, Myriam Benlaïfaoui, Simon Grandjean Lapierre, Nicholas Armstrong, Afnan Al-Saleh, Mélodie Boko, Maxime Jacq, Ian R. Watson, Catalin Mihalcioiu, Arielle Elkrief, Maryam Tidjani Alou, Meriem Messaoudene, Khoudia Diop
Publikováno v:
Microbiology Research, Vol 13, Iss 1, Pp 140-151 (2022)
Fecal microbiome culturomics of a cancer patient treated with immune checkpoint inhibitors led to the identification of a Gram-negative, rod-shaped, obligate anaerobic, non-motile, non-spore-forming bacterium, designated strain kh20T, which was phylo
Externí odkaz:
https://doaj.org/article/133edb383fa74cba9d0a45383600f760